Message from the Director
|
|
Stan Gerson, MD
Director, Case Comprehensive Cancer Center
|
|
I would like to wish you a happy season and hope you all enjoy your holidays! It is all of your good work that is the engine of this cancer center and it simply would not exist without all of you!
As we wrap up 2019, I am proud to highlight some of the leadership, honors, events, grants and accomplishments to illustrate the past year at our exceptional center.
|
|
Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
|
CWRU researchers to lead Northeast Ohio initiative to prevent, detect and treat lung cancer in underserved communities
|
From
The Daily: With a $2.75 million, three-year grant from the Bristol-Myers Squibb (BMS) Foundation, researchers from Case Western Reserve University will lead a community wide initiative to create and apply innovative methods to prevent and detect lung cancer in underserved residents in Northeast Ohio.
|
|
The Community Collaborative for Lung Health Equity, directed by
Monica Webb Hooper, PhD a professor of oncology, family medicine and community health and psychological sciences at the Case Western Reserve School of Medicine, is a model focused on being out in the community to increase access to lung-cancer screening among eligible individuals, and to help them navigate treatment and support services.
“Lung cancer is the most common cause of cancer mortality in Northeast Ohio,” said Webb Hooper, the research project’s principal investigator and director of the Office of Cancer Disparities Research at the Case Comprehensive Cancer Center. “Socioeconomic status and race are related to late-stage presentation and higher lung-cancer death, and we want this project to address those disparities.”
Co-investigators for the initiative include three fellow Case CCC members:
Erika Trapl, PhD,
Anant Madabhushi, PhD, and
Kurt Stange, MD, PhD. They are joined by Catalina Teba, MD, an assistant professor at the School of Medicine and University Hospitals in the effort.
|
|
|
Join the Case CCC Administrative Team: Deputy Associate Director for Administration
|
The Case Comprehensive Cancer Center (Case CCC) is seeking candidates for Deputy Associate Director for Administration. The Deputy Associate Director of Administration is a member of the Case CCC administrative team, working under the guidance of the Associate Director of Administration and responsible for: developing implementation strategies, advising on matters of operational feasibility, providing programmatic and developmental research support; and, supervising the Cancer Center Support Grant (CCSG) primary staff.
|
|
Sossey-Alaoui Lab Seeking Postdoctoral Scholars
|
Postdoctoral Scholar positions in cancer microenvironment and metastasis are available in the laboratory of
Khalid Sossey-Alaoui, PhD at the Division of Cancer Biology, MetroHealth Medical Center, and Case Western Reserve University School of Medicine. Their research focuses on the basic molecular mechanisms underlying cancer invasion and metastasis as well as interactions within the tumor microenvironment in major solid tumor cancers, with a focus on breast, prostate and brain cancers. Highly motivated cancer biologists with PhD, MD, or both degrees, and proven record of research creativity and productivity are welcome to apply. Working experience using transgenic/knockout and xenograft mouse models, Cell Signaling and basic molecular biology techniques is valuable; familiarity with CRSPR/Cas9, cancer stem cells, bioinformatics, or Drug Discovery is a plus. Competitive salary and generous benefit package will be provided for qualified candidates. Case Western Reserve University is an equal opportunity employer.
Several positions are immediately available. Interested candidates should send their CV, and contact information for three references to Dr. Sossey-Alaoui at
kxs586@case.edu.
|
|
Mon, Dec 23 - Wed, Jan 1
CWRU Closed for Winter Break
Case CCC Office Closed
|
|
Fri, Jan 3
Taussig Cancer Institute Grand Rounds
8a CA5-120
|
|
Mon, Jan 6
Cancer Center Research Chalk Talk
1p WRB 3-136
Tumor Immunology and Immunotherapy Meeting
Richard Lee, MD
4p WRB 1-422D
|
|
Weds, Jan 8
Disparities SPORE Meeting
Anant Madabhushi, PhD
5-7p WRB 2-136
|
|
Thurs, Jan 9
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
Adrian Gomez-Nguyen
12p WRB 5-136
Immuno-Oncology Seminar Series
Haidong Dong, MD, PhD
1p NE1-205
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, Jan 10
Taussig Cancer Institute Grand Rounds
8a CA5-120
UH Seidman Cancer Center Grand Rounds
8a Wearn 137
Cancer Center Seminar Series
Erika Trapl, PhD
12p WRB Auditorium
|
|
|
|
4th Annual Cancer Disparities Symposium
March 6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center Office of Cancer Disparities Research will present the
4th Annual Cancer Disparities Symposium
: Cultivating Science and Community Engagement to Address Cancer Health Disparities on March 6, 2020.
The
agenda is now posted and will feature sessions on Cancer Disparities and Underserved Populations, Community Engagement and Support Programs, and Cancer Disparities Research and Community Engagement, plus invited presentations selected from standout abstract submissions. Keynote talks from
Robert T. Croyle, PhD from the National Cancer Institute and
Lucio Miele, MD, PhD from Louisiana State University cap-off the day's innovative agenda.
|
|
|
|
Save The Date: Cancer Stem Cell Conference 2020
August 4-6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center and the National Center for Regenerative Medicine invite you to save the date for CSC 2020! Now in its fourth year, CSC 2020 will feature renowned thought leaders in the field of cancer stem cell research. This conference is guaranteed to offer cutting-edge keynote presentations from a variety of niches within the field. Join world-class investigators for this three-day summit and network with scientists and clinicians advancing cancer stem cell research and therapeutic applications.
Registration will open in February 2020.
|
|
|
|
Additional Upcoming Events
|
|
|
ASH Review
January 22, 2020 5:15-6:45p
Intercontinental Hotel, Cleveland
|
This course will provide hematologists, medical oncologists, radiation oncologists and nurses with current data and information on topics presented at the American Society of Hematology 61st Annual Meeting in Orlando on December 7-10, 2019.
|
|
|
|
Breast Cancer Update: Review of Breast Cancer Symposia
February 12, 2020 11:45a-4:15p
Embassy Suites, Independence
|
This review course will summarize highlights from the national breast cancer meetings, with a focus on the clinical implications of the new information presented at these meetings. Medical oncologists, breast surgeons, radiation oncologists, women’s health, nurses, nurse practitioners, physician assistants, residents and fellows and other health care providers with an interest in the management of patients with breast cancer should attend this course.
|
|
|
|
|
2020 Multidisciplinary Head and Neck Cancer Update
February 14-15, 2020
Fort Lauderdale, FL
|
This course will provide practicing physicians, residents, fellows, and nurses in medical oncology, otolaryngology, radiation oncology, and head and neck surgery with a contemporary update of management strategies of head and neck cancer using a multidisciplinary approach. Lecture and panels will provide a forum for discussion of updated therapies and new treatment innovations.
|
|
|
|
NCCN 2020 Annual Conference
March 20-22, 2020
Orlando, FL
|
|
|
|
Proposals Accepted on a Rolling Basis
Deadline: January 20, 2020
Proposals are accepted on a rolling basis subject to fund availability
Applications accepted and awarded on a rolling basis
Open until all 6 projects are awarded.
Open until all Phase I projects are awarded.
Deadlines: March 1, June 1, Sept 1, Dec 1
|
|
New York Times - Dec 12, 2019
“The people we care for in the hospital are so much more than how they appear during a visit, in their medical records, or in any snapshot in time," writes
Mikkael Sekeres, MD in his latest essay. Dr. Sekeres is Medical Director of the Clinical Trials Unit at Cleveland Clinic Taussig Cancer Institute and Deputy Associate Director for Clinical Research at the
Case CCC.
|
|
Targeted Oncology - Dec 13, 2019
In a Targeted Oncology case-based peer perspectives live discussion,
Nathan A. Pennell, MD, PhD, associate professor of the Department of Medicine at Case Western Reserve University and a medical oncologist at Cleveland Clinic Taussig Cancer Institute, discussed treatment options for EGFR-mutant non–small cell lung cancer, based on the case of a real patient.
|
|
Weekly NIH Funding Opportunities and Notices
|
|
Use the button below to submit all your news, events, announcements and communications requests to the Case CCC Marketing and Communications team!
|
|
|
|
|
|
|